ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,624.10
0.49%
S&P ASX All Technology
3,018.80
1.56%
Brent Oil
83.77
0.17%
US Dollar vs AUD
1.52103
-0.05%
Bitcoin
59,608.49
0.82%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Catalyst Pharmaceuticals Inc (CPRX)

  7. Catalyst Pharmaceuticals Inc (CPRX) News

CPRX Catalyst Pharmaceuticals Inc

14.8638
-0.3362 (-2.21%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Catalyst Pharmaceuticals Inc CPRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.3362 -2.21% 14.8638 06:38:57
Open Price Low Price High Price Close Price Previous Close
15.33 14.84 15.47 15.02 15.20
more quote information »

Recent News

Date Time Source Heading
01/5/202422:00GLOBECatalyst Pharmaceuticals to Participate at the BofA..
22/4/202422:00GLOBECatalyst Pharmaceuticals to Report First Quarter 2024..
28/3/202423:03GLOBECatalyst Pharmaceuticals Announces Support for the Inaugural..
27/3/202423:03GLOBECatalyst Pharmaceuticals to Participate in the 2024 Cantor..
13/3/202422:55GLOBECatalyst Pharmaceuticals Announces AGAMREE® Now Commercially..
06/3/202400:03GLOBECatalyst Pharmaceuticals to Participate at the Barclays 26th..
29/2/202410:03GLOBECatalyst Pharmaceuticals Reports Strong Fourth Quarter and..
28/2/202400:03GLOBECatalyst Pharmaceuticals to Present at MDA Clinical &..
22/2/202401:00GLOBECatalyst Pharmaceuticals Announces Publication of Santhera..
17/2/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:03GLOBECatalyst Pharmaceuticals to Report Fourth Quarter and..
10/1/202409:15EDGAR2Form 8-K - Current report
10/1/202408:05GLOBECatalyst Pharmaceuticals, Inc. Announces Closing of Public..
09/1/202400:10EDGAR2Form 8-K - Current report
06/1/202409:23EDGAR2Form 8-K - Current report
06/1/202409:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/1/202400:02GLOBECatalyst Pharmaceuticals, Inc. Announces Pricing of Public..
05/1/202408:49GLOBECatalyst Pharmaceuticals, Inc. Announces Proposed Public..
04/1/202409:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202409:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202409:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202308:30EDGAR2Form 8-K - Current report
18/12/202322:30GLOBECatalyst Pharmaceuticals Announces FIRDAPSE® New Drug..
16/12/202305:47EDGAR2Form 144 - Report of proposed sale of securities
14/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202306:57EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

NASDAQ
CPRX
Catalyst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved